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Summary 
We have analyzed B  cell tolerance in a rheumatoid  factor (RF)  transgenic mouse model.  The 
model  is  based  on  AM14,  a  hybridoma  originally  isolated  from  an  autoimmune  MRL/lpr 
mouse that has an affinity and specificity typical of disease-related RFs from this strain.  AM14 
binds  to immunoglobulin  (Ig)G2a of the  "a"  allotype  (IgG2a  a)  and  not  to  IgG2a  u.  Thus,  by 
crossing  the  transgenes  onto  an  IgH  a (BALB/c)  background  or  to  a  congenic  IgH  b  (CB.17) 
background,  we could study the RF-expressing B  cells when they were self-specific (IgH  9  or 
when they were not self-specific (IgHb). These features make the AM14 model unique  in fo- 
cusing  on a  true  autoantibody  specificity while  at the  same time allowing comparison  of au- 
toreactive  and nonautoreactive  transgenic  B  cells,  as was possible in model autoantibody  sys- 
tems such as anti-hen  egg lysozyme. Studies showed that AM14 RF B  cells can make primary 
immune responses and do not downregulate  slgM, indicating  that the presence of self-antigen 
does not induce  anergy of these cells.  In fact, IgH  a AM14  transgenic  mice have higher serum 
levels of transgene-encoded  RF than their IgH  b counterparts,  suggesting that self-antigen-spe- 
cific activation occurs even in the normal mouse background.  Since AM14  B  cells made pri- 
mary responses, we had the opportunity to test for potential blocks to self-reactive cells enter- 
ing  the  memory  compartment.  We  did  not  find  evidence  of this,  as  AM14  B  cells  made 
secondary immune responses as well. These data demonstrate that a precursor of a disease-spe- 
cific autoantibody can be present in the preimmune repertoire and functional even to the point 
of memory cell development of normal mice. Therefore,  immunoregulatory  mechanisms  that 
normally prevent autoantibody production  must exert their effects later in B  cell development 
or through T  cell tolerance. Conversely, the data suggest that it is not necessary to break central 
tolerance,  even in an autoimmune  mouse,  to generate pathologic,  disease-associated autoanti- 
bodies. 
N 
egative regulation of self-reactive B cells, "tolerance," 
can occur at multiple points during B cell development 
(1-6).  In the bone marrow (BM) I, newly formed self-reac- 
tive  ceils  can  be  eliminated  ("clonal  deletion")  (1,  6,  7), 
modified by further rearrangement  of the  Ig receptor ("re- 
ceptor  editing")  (8,  9),  or  inactivated  to  prevent  Ag-spe- 
cific  responses  ("clonal  anergy")  (3,  4,  10).  Self-reactive 
cells escaping to the periphery can also undergo deletion on 
encountering  self-Ag in organs such as the liver (11).  Fur- 
ther,  self-reactive  cells  that  are  stimulated  by  Ag  may be 
subject to a less-defined form of negative regulation during 
1Abbreviations used in  this paper: BM,  bone  marrow;  HEL,  hen  egg 
lysozyme; Tgic, transgenic. 
memory  cell  differentiation  accompanying  a  primary  im- 
mune response (12-15).  It is also clear that some nominally 
self-reactive  B  cells may not  be  tolerized  at  all  (16-19),  a 
state which has been called "clonal ignorance"  (20). Nega- 
tive regulation  of self-reactive B  cells could also be accom- 
plished less directly, for example, via T  cell tolerance or by 
efficiently downregulating  ongoing  antiself responses.  It is 
not  clear  which,  if any,  of these  regulatory  mechanisms 
break down during systemic autoimmune disease, although 
the multistep  nature  of self-tolerance argues against a  gen- 
eral breakdown. 
Why some self-reactive B  cells are subject to one or an- 
other of these forms of negative regulation or are not regu- 
lated  at  all is not  clear.  Whether  the  self-Ag is soluble  or 
membrane bound may play a role (1, 4, 7). Affinity for self- 
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that  dictate  the  timing  and  site  of encounter,  availability, 
and valency of interaction  with  self-reactive B  cells  could 
also be important.  To understand why certain self-reactive 
B cells are subject to particular forms of tolerance is critical, 
in view of the  fact that specific self-Ags are targets in sys- 
temic  autoimmunity,  and  that  these  targets  differ  among 
various  systemic  autoimmune  diseases  (22).  For  example, 
anti-dsDNA  is  a  hallmark  of SLE  (23,  24)  while  R.Fs  are 
most common in rheumatoid arthritis  (25, 26). In addition, 
in SLE patients or in MRL/Ipr/Ipr mice, only a fraction of 
individuals make anti-Sm (22, 24, 27). Therefore, most lu- 
pus patients  are tolerant of their own Sm, at least  at the B 
cell level. The selective loss of self-tolerance that character- 
izes systemic autoimmune diseases  may reflect the dihVerent 
levels  of B  cell tolerance  that  occur for different autoAbs. 
Our long-term goal is to understand  why and how selec- 
tive loss of self-tolerance occurs in autoimmune disease. 
In  this  regard,  the  recent  work  of Goodnow and  col- 
leagues  (1,  4,  5)  using  an  anti-hen  egg lysozyme  (HEL)/ 
HEL Tgic system, and Nemazee and colleagues (2, 7) using 
an anti-MHC  class  I  transgenic  (Tgic)  system may not be 
indicative  of  disregulation  in  autoimmune  disease.  Al- 
though their studies have verified the existence of autono- 
mous B  cell tolerance and have revealed both mechanisms 
and  sites  of B  cell  tolerance  (9,  28-31),  the  specificities 
studied do not have any obvious correlate among actual au- 
toAbs.  Therefore,  these models do not help  to explain  se- 
lectivity of autoAb production and may not be representa- 
tive  of actual  autoAb-producing B  cells.  To  address  some 
of  these  concerns,  several  groups  have  generated  Tgic 
mouse models using V genes from spontaneously generated 
autoAb-producing  cell  lines  isolated  from  autoimmune 
mice  (8,  32-36).  Tgic models using real autoAgs have re- 
vealed that at least  certain self-specific B  cells  can be  cen- 
sored from the preimmune repertoire via either deletion or 
anergy. For example,  DNA-specific B  cells  can be deleted, 
anergized,  or edited  (8,  32,  33,  36),  while  antierythrocyte 
B  cells  are  variably  activated,  anergized,  or  deleted  (34). 
However, interpretation  of these models is also limited for 
two  reasons:  first,  as  in  the  facultative  autoAb  Tgics,  in 
both the DNA and erythrocyte systems, high affinity mu- 
tated autoAbs have been put back into the germline and so 
developing B  cells  may not mimic the fate  of the  original 
unmutated  precursors  that  were  first  activated.  Second, 
clear interpretation  of data is hampered by constitutive au- 
toAg  expression,  which  precludes  Ag-negative  controls 
possible in the anti-HEL or anti-class I systems. 
To ask whether the B  cell precursors of a bona fide au- 
toAb are  tolerized  in  a nonautoimmune  mouse  while  ad- 
dressing the concerns inherent in previous models, we cre- 
ated the AM14 P,F Tgic model (16).  In the AM14 model, 
rearranged V  genes from an RF (specific for IgG2a  ~ but not 
IgG2a  b)  originally  isolated  from  an  MRL/lpr/lpr  mouse, 
have  been  placed  in  the  germline.  AM14  has  a  typical 
moderate affinity and has few if any somatic mutations, and 
so is a logical candidate for a germline or near-germline au- 
toAb. Most importantly, the specificity for IgG2a  :' allows us 
to generate Ag-negative (IgH  b) and autoAg-expressing (IgH  a) 
mice by crossing onto appropriate backgrounds. 
In earlier work  (16),  we determined  that AM14 B  cells 
were  not  subject  to  clonal  deletion  in  a  nonautoimmune 
BALB/c background.  In the  present  work,  we show  that 
these  cells  are not subject  to  the  second major form of B 
cell tolerance--anergy. We also show that such B  cells  can 
participate  in  memory responses.  Thus,  these  self-specific 
tkF B  cells nonetheless appear fully immunocompetent in a 
normal mouse. We conclude, in contrast to earlier sugges- 
tions based on artificial autoAb Tgics  (4,  37),  that  neither 
central nor peripheral tolerance mechanisms are responsible 
for regulating  bona fide  P,.F autoAb precursors  in  normal 
mice.  Instead, these results suggest that events leading to B 
cell autoimmunity act at later stages either in aberrant B cell 
activation or in failure  to appropriately downregulate acti- 
vated autoreactive B  cells. 
Materials and Methods 
Mice 
Tgic mice were constructed as described  (16). H  chain Tgics 
were bred onto the CB. 17 (IgH  b) background. Originally,  two H 
chain Tgic lines were described  and found to be similar. All work 
reported here is on one of those lines.  L chain Tgics  were bred 
onto both the  CB.17  and BALB/c (IgH  ~) backgrounds.  At the 
18th  BC  generation,  L  chain  mice  of both  types  were  inter- 
crossed to obtain homozygous Tgics (as confirmed by test crosses) 
which were  maintained  by continuous intercrossing  and which 
were used in all experiments.  To obtain RF-specific double Tgic 
mice, male H  chain Tgics were bred to female  L chain Tgics of 
either the BALB or CB.17 background. Thus HL double Tgics 
were obtained with either the IgH  "~/b (experimental)  or the IgH  b/l' 
(control)  background.  Mice  were  genotyped  by  PCR  as  de- 
scribed  (16), Genotypes  were  reconfirmed  in  all  experimental 
mice using either a specifc antiidiotype assay or PCFZ of recut 
tails or both. BALB/c mice were obtained from the Jackson Lab- 
oratory  (Bar  Harbor,  ME)  or from  our  own  breeding  colony 
which had been established with breeding pairs from the Jackson 
Laboratory.  CB.17  mice  were  from  our  colony derived  from 
breeding pairs obtained from Taconic Farms, Inc.  (Germantown, 
NY).  All  mice  were  maintained  in  our  specific-pathogen-free 
barrier  facility.  The  H  and  L  chain  Tgic  nucleus  colony  was 
maintained in microisolator cages. 
ELISA and ELISA Spot Assays 
ELISA assays for IgM, IgM  '~, lgG2a, and RF were performed 
as described  (16). A sandwich anti-Id ELISA and ELISAspot assay 
were  used  to  unambiguously distinguish  Tg-derived  RF  from 
background RF derived from non-Tgic cells. Two antiidiotypes, 
both specific for the Tg-encoded HL combination, were derived 
as previously described,  and purifed and biotinylated as described 
below (16). For ELISA, plates (lmmulon 2; Fisher Scientific  Co., 
Pittsburgh,  PA) were coated with 8 btg/ml of 4-44 overnight in 
BBS,  washed,  and blocked with  l% BSA/PBS.  Serially diluted 
samples were incubated in duplicate  for 1 h, followed by wash- 
ing,  detection with  4G7-biotin  ((t.25 Ftg/ml in  1% BSA/PBS), 
washing, incubation with streptavidin-alkaline  phosphatase (South- 
em Biotechnology, Birmingham, AL) diluted  1:t,500, and finally 
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Na carbonate/10 mM MgC12.  Plates were read on an EL390 mi- 
croplate spectrophotometer (Bio-Tek Instruments,  Inc., Burling- 
ton, VT) and concentrations determined using Deltasoft (Biome- 
tallics, Princeton,  NJ) by comparison to standard  curves on each 
plate. ELISAspot was carried out similarly, except that either 4G7 
(8 p~g/ml)  or goat anti-mouse IgM antiserum (10 p,g/ml; South- 
ern Biotechnology) was used to coat plates and 4-44-biotin used 
to  detect  (0.6  Ixg/rnl).  Splenocyte  single  cell suspensions  were 
made  in RPMI  1640  (GIBCO-BIkL,  Gaithersburg,  MD)/2.5% 
FCS and were plated directly onto coated, blocked plates in trip- 
licate. Serial dilutions were carried out in the plate. Cells were in- 
cubated for 4.5-6 h.  in a total volume of 200  p  J/well at 37  ~ C. 
All washes were done with PBS/1% Tween 20 (3￿  followed by 
dH20 (2￿  between each step. Final development was with 80% 
bromochloroindoyl phosphate solution (Sigma Chemical Co., St. 
Louis, MO) in 0.6% low melting point agarose (FMC Corp. Bio- 
products, Rockland, ME). Spots were read using a dissecting mi- 
croscope. All wells from a single assay were read at the same sit- 
ting.  Data  were  analyzed  by  extrapolating  from  dilutions  that 
yielded 20-150 spots in a well or from wells which contained the 
greatest number of spots if <20. 
FA CS  ~ Analysis 
FACS  |  analysis  was performed as described (16). 
Antibodies and Ags 
Antibodies were obtained and purified as described (16).  Puri- 
fied Abs were biotinylated as described (16).  TNP-KLH was pre- 
pared according to (38).  KLH was originally obtained from Cal- 
biochem Corp., LaJolla, CA. Before derivitization, high molecular 
weight KLH was isolated by ultracentrifugation. 
Transfer Immunization 
Cell Preparation.  Single cell suspensions  were  prepared  from 
spleens  of 12-wk-old  RF  Tgic or  11-14-wk-old  bone  marrow 
chimeras.  Splenocytes  were  depleted  of T  cells  by  incubating 
with J 1J (anti-Thy-1)  culture supernatant,  followed by treatment 
with  guinea  pig complement  (GIBCO-BIkL).  T-depleted  sple- 
nocytes (referred to as B  cells in the text) were washed into PBS 
just before injection.  8-10-wk-old BALB/c T  cell donors  were 
immunized with  100  p,g KLH in CFA (GIBCO-BRL) subcuta- 
neously at the tailbase and right footpad 1 wk before killing. Cells 
were teased from inguinal and popliteal lymph nodes and main- 
tained in media  containing 40  Ixg/ml DNAse  (Sigma Chemical 
Co.).  Lymph node cells were depleted of B  cells and some mac- 
rophages by incubation with MKD6  (anti-I-A  d) and JllD  (anti- 
HSA)  supernatants  followed by  treatment  with  rabbit  comple- 
ment (Cedarlane Laboratories Ltd., Homby, Canada). B-depleted 
LN cells (referred to as T  cells in the text) were washed into PBS 
supplemented  with  20  mM  Hepes  (GIBCO-BR.L)  and  2.5% 
ACD-A (Baxter-Fenwal, Deerfield, IL) just before injection. Ali- 
quots  of B  and  T  cell-enriched preparations  were  analyzed  by 
FACS  |  (using anti-Lyl to identify T  cells and anti-B220 to iden- 
tify B  cells)  to  confirm depletion of target  cell populations,  and 
enumerate  Id + B  cells (using the AM14 ant-id 4-44).  Generally, 
T-depleted preparations had <2% residual T  cells and B-depleted 
populations had <3% residual B  cells. 
Antigen Preparation.  Hyl.2  mAb  (IgG2a  a anti-TNP)  or con- 
trol  C4010  (IgG2a  b anti-TNP)  was  incubated  with  TNP-KLH 
for  1 h  at  37~  to  allow formation  of Ag-Ab complexes.  Each 
dose of cell/Ag mixture contained  125  I,  Lg Hyl.2 or C4010  and 
31.2 p,g TNP-KLH. 
Injections.  Each recipient received 2  ￿  106 T-depleted sple- 
nocytes from Tgic donors or, in the case of BM chimera donors, 
0.8  X  106 Id+  B  cells. All recipients received 4-6  X  106 T  cells 
and  Ag or control immunogen  as indicated  in  figures and  text. 
Sublethally irradiated  (550  R)  8-wk-old BALB/c and  7-9-wk- 
old CB.17 recipients were given the cell/Ag mixture via i.v. in- 
jection in the lateral tail vein, within 6 h  of irradiation.  Cells and 
Ag were mixed just before injection. Recipients were given acid- 
ified water until being killed. 
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Figure 1.  RF Tgics that  express the IgG2a  ~ autoantigen  have higher 
levels of spontaneous serum RF. tkF Tgic mice oflgH  a/b (HL  Jb) or IgH  b 
(HL  b) genotypes were bled and serum lgM, IgM anti-IgG2a% and AM 14- 
ld were determined  in micrograms per milliliter based on standard curves 
derived  from an  irrelevant  IgM and  a  transfectoma  expressing an  IgM 
identical to the Tg IgM. The values of the ratio of lgM anti-IgG2aVIgM 
total  (A) or AM14-Id/IgM total  (B) are shown,  with each point repre- 
senting a single mouse. Horizontal bars in each column denote the means. 
For each ratio,  HL  ~/b animals have higher serum levels indicative  of the 
Tgic protein  (four to five time higher on average). The two ratios were 
highly correlated among individual mice (not shown). Non-Tgic, L only, 
or H only mice generally had values <0.5% (not shown). 
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RF, Idiotype 
Bone Marrow Chimeras 
BM was  harvested from femurs,  tibias,  and  humeri  of 9-wk- 
old BALB/c,  14-wk-old CB.17 and individual 8-13-wk-old RF 
Tgic  mice.  Aliquots  from  each  Tgic  donor  were  analyzed  by 
FACS  |  to confirm presence  of Id + B  cells.  Cells from BALB/c 
and a/b Tgic were pooled in various ratios,  as were CB.17 and b/b 
Tg cells. A  total of 1.4  ￿  107 bone marrow  cells in PBS were 
injected  i.v.  into  each  allotype-matched  9-wk-old  BALB/c  or 
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Figure  3.  FACS  |  analysis of primary transfer imnmnization  ofTgic P,.F 
B  cells. Mice prepared  and  immunized  as  described  in  Materials  and 
Methods  and Fig. 2 were killed 7 d after immunization  and aliquots of 
spleen cells were analyzed by FACS  |  2% probability plots are shown and 
percentages of total live cells (as determined  by propidium  iodide dye ex- 
clusion) in each gate are indicated.  The ordinate  shows expression of the 
AM14  (4-44) idiotype  and  the abscissa total  surface IgM.  Each  plot is 
from a different mouse from the same experiment  which compared  the 
absence of autoantigen  (IgH 1', A and  B) to the presence  of autoantigen 
(IgH% C and D) and the use of IgG2a" immunogen (A and C) to control 
IgG2a  b immunogen (B and D). Note that variability in the frequency  of 
lgM+/Id  (17--2  gate) cells was seen in multiple  recipients in multiple  ex- 
periments  regardless of treatment  group.  We suspect that  this represents 
variable autoreconstitition  of endogenous  B cells 7 d after sublethal irradi- 
ation. 
&mndmj  Immunization 
4-5 weeks 
Reimmunize  / 
Figure  2.  Transfer imnmnization  pro- 
tocols. Shown is a diagram of the trans- 
fer  immunization  schemes  for  primary 
and  secondary  (box) immunization,  as 
described  more  fully  in  Materials  and 
Methods.  T denotes TNP, as derivitized 
onto the KLH carrier protein. 
10-14-wk-old  CB.17  recipient,  irradiated  (650  R)  6  h  earlier. 
Recipients  were  kept  in  microisolator cages  and  provided  with 
acidified water until being killed. 
Results 
Autospecific RF B  cells Are Not Anergic 
We have shown that AM14 R,F B  cells are not deleted in 
IgG2aa-expressing  mice  (16).  To  determine  the functional 
capacity  of these  potentially  autoreactive  B  cells,  we  as- 
sessed both spontaneous serum Ab and the response of Tgic 
B  cells to immunization. 
Serum AutoAb.  We  compared  the level of serum  IgM- 
RF  and  AM14-idiotype  in  control  IgH  b  (lacking  autoAg) 
and  IgH  a/b  AM14  Tgic  mice  from  two  different  founder 
lines  (16).  Fig.  1  summarizes  the  data  from  multiple  indi- 
vidual mice from  one  of the  founders.  Measured  as  either 
IgM-anti-IgG2a a  R.F  or  as  AM14-idiotype,  spontaneous 
serum  Tgic Ig was  significantly higher in  the  IgH  a/b mice. 
Similar data were obtained for the other founder (reference 
[16]  and  not  shown).  Finding  higher  RF  levels  in  IgH  ~/b 
compared  to  IgH  b/b mice is contrary  to  the  expectation  of 
anergy in IgH  Jb mice. However, it does not by itself estab- 
lish that R.F B  cells in IgH  a/b mice are immunocompetent. 
Immunization.  To directly test the capacity of such cells 
to participate  in primary immune  responses,  we established 
a transfer immunization assay.  T  cells were primed to KLH 
in  normal  animals,  and  transferred  into  sublethally  irradi- 
ated  recipients,  along  with  naive  Tgic  B  cells  and  TNP- 
KLH  +  IgG2a  a anti-TNP  Ag  (Fig.  2).  Immune  responses 
of Tgic B  cells were assayed by FACS  |  (Fig.  3)  and ELISA 
spot (Fig. 4) analysis of recipient splenocytes.  No  difference 
was seen between Ag-positive (IgH  ~'/b donors into  IgH  ~ re- 
cipients)  and  Ag-negative (IgH  b/b donors  into  IgH  b recipi- 
ents)  transfers.  In  each  case,  responding  cells  could  com- 
prise up to 20% of recipient spleen, implying a large degree 
of proliferation  (Fig. 3  and data not shown).  Such cells also 
had  increased  forward  scatter,  consistent  with  activation 
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Figure 4.  ELISAspot analysis of primary transfer immunization ofTgic RF B cells. Mice prepared and immunized as described  in Materials  and Meth- 
ods and Fig. 2 were killed  7 d after immunization and aliquots  of spleen  cells analyzed  by ELISAspot for IgM+/AM14-I& Ab-fonning cells. Each panel 
shows the result  of an independent experiment. Each column shows recipients derived from a single donor mouse; under each  column is given the Tg 
type (HL) and lgH type (either b or a/b) of the donor. Treatment groups are indicated  by different  symbols (see key).  All groups received T  and B cells 
as outlined in Fig. 2, except as denoted in the key to the symbols. In some treatment groups multiple recipients  received the same treatments and are rep- 
resented by individual  symbols. Error bars shown for each individual  recipient are the SEM of triplicate  determinations; many error bars are smaller than 
the symbols and are obscured. All data are expressed as lgM+/AM14-Id  + AFC/spleen. In cases where no spots were seen at the highest cell concentration 
on ELISAspot plates, the upper 95% confidence limit of detection sensitivity  was taken  as the result. 
(not shown).  Large increases in the number of spot-form- 
ing cells were also evident. Controls performed using either 
the T  cell Ag alone (TNP-KLH), the B cell Ag alone (IgG2a 
anti-TNP) or complexes of the B cell Ag with an irrelevant 
T  cell Ag  (IgG2a anti-TNP  +  TNP-rabbit-IgG)  (Fig.  4; 
see legend) all gave background responses. Together, these 
data show that B cell activation, proliferation, and differen- 
tiation were unaffected by the presence or absence of au- 
toantigen  during  the  development  and  immunization  of 
the B cells. 
Memory Responses 
Since  chronic  autoantibody  responses  in  autoimmune 
individuals  resemble memory responses,  a  candidate  stage 
for regulation of autoreactive cells is memory cell differen- 
tiation.  As  autoreactive AM14  B  cells  made  primary im- 
mune responses,  this  provided the  opportunity to  test for 
regulation  of secondary responses.  We  modified our pri- 
mary adoptive transfer assay as follows  (Fig.  2):  Instead of 
killing animals 1 wk after immunization, we waited 4-6 wk 
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and reimmunized them with immune complexes (or PBS) 
i.v. in saline, Few spontaneous antibody-forming cells and 
Tg-idiotype expressing B cells were detected in mice given 
PBS 4-6 wk after primary immunization and assayed 1 wk 
after PBS injection (Fig.  5).  Similarly, AM14-Id positive B 
cells were undetectable (<0.1% of splenic cells) in the mice 
that received PBS in lieu of the second immunization (data 
not shown).  This demonstrated that the primary response 
had concluded during the 4-6 wk wait and that the vigor- 
ous secondary response was not due to a large number of 
residual  precursor  cells.  Mice  given  a  second injection  of 
immune  complexes made strong immune  responses,  with 
large numbers of double-Id  § antibody-forming cells (Fig. 5) 
and detectable Tg-idiotype expressing splenocytes (data not 
shown).  Again,  no  difference  was  observed between  au- 
toreactive (i.e., from IgH  a/b donors transferred to IgH  a re- 
cipients)  and  nonautoreactive  (IgH  b donors  transferred  to 
IgH  b recipients) Tgic B cells. Specificity controls (see Fig.  5) 
demonstrated that the secondary response is Ag specific and 
T  cell dependent.  Thus, we conclude that autoreactive RF B  cells are not blocked from functional memory develop- 
ment even in normal mice. 
Mixed Bone Marrow Chimeras 
Presumably owing to allelic exclusion by the IgM trans- 
gene, serum IgG2a  ~ levels are on average fivefold lower in 
adult  (8-16  wk)  1LF  Tgic  mice  (40  btg/ml)  compared  to 
BALB/c mice  (200  ~g/ml)  (16).  It was  therefore possible 
that the Ag concentration in AM14 Tgic mice was below 
the level required to induce tolerance. To assess the effects 
of higher IgG2a  ~ levels on  AM14  B  cells, we  constructed 
radiation  chimeras  by  reconstituting  normal  mice  with 
mixtures of Tgic and normal bone marrow. In such chime- 
ras,  P,F  Tgic  13  cells  develop  as  a  minority  population 
amidst normal B  cells and these normal B  cells should re- 
store near-normal levels of serum  IgG2a  a Ag.  In addition, 
any effects due to a preponderance of Tgic B  cells, such as 
lack of competition for follicular niches (31), would be ne- 
gated in such mixed chimeras. 
To  obtain a population of 5-15%  Tg-expressing B  cells 
6-10-wk  after transfer a  10-20:1  ratio of Tg:normal mar- 
row was  required  (Fig. 6  A). Repopulation of the splenic 
B  cell compartment was indistinguishable in antigen-nega- 
tive  (IgH  6/b  +  CB.17  BM  --+  CB.17)  or  antigen-positive 
(IgH  '~/b +  BALB/c BM -+ BALB/c) chimeras. As expected, 
given the high frequency of non-Tgic B  cells, most of the 
recipient mice achieved normal IgG2a  a serum levels at the 
time of assay. Time course analysis of serum IgG2a  ~ levels 
further suggested that chimeric mice had near-normal lev- 
els (i.e., >100  p~g/ml) of IgG2a  ~ for at least several weeks 
before killing (Fig. 6 B). Thus, the chimeras did in fact pro- 
vide an environment  for naturally derived high Ag levels. 
P,  econstitution was  equivalent in IgH  ~ or IgH  b recipients. 
Thus,  even when the Tgic B  cells were a minority popula- 
tion, no deletion was seen. 
We tested B  cells isolated from mixed BM  chimeras for 
the characteristics ofanergy using the transfer immunization 
assay. In two separate experiments with multiple indepen- 
dent chimeric mice as B  cell donors,  we found equivalent 
responses of R.F Tgic B  cells in either the antigen-positive 
or antigen-negative context (Fig. 7). We conclude that even 
at IgG2a  ~ autoAg levels in the range for a normal BALB/c, 
self-reactive RF B  cells make normal primary immune re- 
sponses and do not appear anergic. 
Discussion 
AM14 RF Tgics, unlike previous autoAb Tgics (1, 2, 4, 
5,  7,  8,  32-36),  show  that  disease-related, self-specific B 
cells can be immunocompetent in a nonautoimmune mouse. 
AM14  Tgic B  cells were  not anergic as determined by an 
assay system that closely resembled the one used by Good- 
now  and  colleagues  (4)  to  define  anergy in  Tgic  B  cells. 
Nor do AM14 B  cells exhibit receptor downregulation  in 
the  presence  of autoAg,  as is seen  in  anergic  anti-HEL B 
cells (16). Furthelznore, serum levels ofTgic Ig (assayed ei- 
ther as RF or idiotype) are elevated, not reduced, in mice 
that  had  the  autoAgic  IgG2a  ~.  Anti-HEL/sHEL  double- 
Tgic mice had much reduced levels ofTgic Ig (4). Indeed, 
the elevated RF levels in Ag-positive RF Tgics in comparison 
with Ag-negative controls, suggest specific self-Ag-depen- 
dent activation of Tgic B  cells and further support the idea 
that  autospecific  RF  B  cells  are  immunocompetent.  Al- 
though we have not yet defined the details of such activa- 
tion, we suspect that endogenous IgG2aa-driven activation 
is limited to a minority of cells since only "q0%  of serum 
IgM in IgH  a/b mice is of Tg origin (vs. 2%  in  IgH  b mice) 
even though  >95% of splenic B  cells express the AM14 Id 
by FACS  | 
As the RF  autoAb Tgic system demonstrates a  primary 
immune  response,  we  can  examine whether the  constitu- 
tive presence of autoantigen selectively blocks a secondary 
autoAb response. This question is of interest because natu- 
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Figure  5.  ELISAspot  analysis of secondary immunizations. Initially, 
primary transfer inmmnizations were carried out as for Fig. 4 except that 
recipients received splenocytes pooled from  three  to  four Tgic donor 
lmce. 4-6 wk after prinlary immunization, recipients were reimmunized 
(as detailed in the box m Fig. 2). lLesults  of two independent experiments 
are shown. Each column shows a separate treatment protocol as indicated 
by primary immunization/secondary immunization. Cx is IgG2a" anti- 
TNP  +  TNP-KLH mmmne complexes. In the second experiment one 
group received lgG2a" complexes first and IgG2a  L' complexes as secondary 
immunization. IgH" donor/recipient  results are indicated in open circles 
and lgH  b donor/recipient  results in closed circles. Error bars show SEM 
for triplicate determinations from each recipient mouse. All data are ex- 
pressed as AMI4-1d + AFC/spleen, as determined using the double idio- 
type assay  described in Materials and Methods. This assay gives similar re- 
sults to the IgM/ld assay but is more specific and less sensitive, yielding 
absolute values of I or more orders of magnitude fewer total cells than the 
IgM/ld assay. 
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Figure  6.  Generation  and characterization of mixed 
BM chimeras. (A) shows FACS  |  analysis  of splenocytes 
of representative mixed BM chimeras 8 wk after BM 
transplant. Above each panel is indicated  the donor in- 
oculum. Note  that  a  20:1 ratio of Tg:normal BM 
yielded a 1:3 to 1:4 ratio of B cells in spleen 8 wk later. 
No  difference was seen between potentially autoim- 
mune (BALB/c IgH  ~) and control (CB.17 lgH  b) trans- 
fers. (B) Serum IgG2a  ~  levels  in nfixed  BM chimeras  de- 
rived from BALB/c and Tg  donors. Normal serum 
IgG2a levels in 8-10-wk-old mice in our colony are 
~100  Ixg/ml (reference and data not  shown). Note 
that BM chimeras reach near norulal levels at 8 wk and 
normal levels  at 12 wk after transplant. 
ral RF responses in normal mice are transient, are mainly 
restricted to lgM, and do not demonstrate other character- 
istics of memory. In contrast, RF responses in autoimmune 
mice  resemble  secondary  immune responses.  If autoAb- 
producing B cells were blocked from the memory pathway 
in nomlal mice, but not autoimmune mice, this might pro- 
vide  an explanation for  secondary autoimmune responses 
only in autoimmune mice. 
To  test  for  tolerance  in  the  secondary  response,  we 
adapted our transfer immunization assay as shown in Fig. 2. 
By this protocol we found secondary responses in both Ag- 
negative  controls  and  in Ag-positive  experimental mice. 
Thus, we found no evidence that physiologic autoAg im- 
pedes the  development of memory cells. As yet, we have 
not been able to  assay  events which  often correlate  with 
memory,  such  as  isotype  switch  and  somatic  mutation. 
Such assays are difficult in the IgM Tgic setting. Nonethe- 
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less,  we have shown that R.Fs can satisfy  the fundamental 
definition of memory: functional persistence of the second- 
ary response. The observation of secondary AM14 responses 
in spite of the presence of autoAg is relevant to hypotheses 
that posit a window of particular sensitivity to self-Ag tol- 
erance at the memory differentiation stage of Ag-driven B 
cell development (12,  14, 39-42). It has also recently been 
shown that ongoing gemlinal center reactions can be aborted 
by infusion of large amounts ofAg, a result which has been 
interpreted to demonstrate sensitivity to tolerization during 
memory B cell differentiation (12,  13, 43). The fact that we 
did  not  observe  physiologic  inhibition of secondary  re- 
sponse development in the presence of autoAg may reflect 
the specific conditions of our assay.  In our case modest (al- 
beit physiologic) levels  of autoAg were  present constitu- 
tively while in passive administration ofself-Ags large doses 
were injected at particular time points. 1000 
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Figure  7. 
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ELISAspot analysis of transfer immunization of splenocytes 
derived from mixed BM chimeras. Data are represented as in Fig. 5. Two 
independent experiments are shown. Each column shows either an lgH ' 
donor/recipient pair (BALB/c) or an IgH  b pair (CB.17). There is no sig- 
nificant difference between  the  two  types in  either experiment.  PBS- 
immunized mice that showed no spots in any of triplicate wells are indi- 
cated as having one spot per spleen. 
Of the autoreactive Ig Tgic systems that have been de- 
scribed,  the  AM14  system  is  novel  in  design  and  results. 
Systems that demonstrated anergy or deletion used faculta- 
tive autoantigens which are not characteristic targets of spon- 
taneous autoimmunity.  Systems that used classical SLE tar- 
gets, such as DNA  or 1LBC,  also seemed to show deletion 
or  anergy,  but  in  these  cases,  the  interpretation  was  not 
straightforward, since the autoAg is inevitably constitutive. 
In  our  lq.F system we  have  introduced  self-Ag as a  novel 
Ag (in  IgH  b controls)  or as a self-Ag, and in  this case ob- 
served neither anergy nor deletion. 
Why is autoreactive RF not tolerized? One possibility is 
the affinity of the interaction between l~F Ab and the IgG- 
Fc.  The  moderate  affinity of AM14  for  IgG2X' is  distinct 
from  the Abs represented in  the  other models: Anti-HEL 
and anti-Class I Abs are high affinity Abs derived from hy- 
perinmmnized mice, and classic autoAb Tgics such as 3H9 
(8, 32) were constructed with highly mutated V  genes cod- 
ing for Abs  known  to  have  undergone  significant affinity 
maturation. Thus, although 3H9 appears to be deleted and/or 
edited (8,  32),  the  fate  of the much  lower affinity unmu- 
tated precursor (that bound only ssDNA) is as yet unknown. 
The role of affinity cannot be considered in isolation. Au- 
toAg concentration  and  valency must  also  be  considered. 
IgG2a concentrations in AMI4 Tgics are nmch higher than 
soluble  lysozyme  concentrations  in  the  HEL  model  and 
therefore  would  be  expected to  compensate  to  some  de- 
gree for the lower affinity of AM14. In fact, the products of 
the  estimated affinity and  molar  concentration  of Ags  for 
each of the two systems are similar (16).  Perhaps AM14  is 
near  an  affinity  threshold  required  for  anergT,  or  the  in 
vivo  valency  of lysozyme  is  greater  than  IgG2a,  thereby 
mediating more cross-linking. In  this regard, AM14  mice 
may  be  similar to  anti-Class  I  mice  that  expressed  small 
amounts  of soluble Class I  autoAg or low levels of soluble 
HEL (5,  11). These mice did not show reduced serum lev- 
els  of anti-Class  I  or  anti-HEL,  but  whether  the  B  cells 
were  indeed  anergic  was  not  directly investigated  in  the 
case of anti-Class I. 
Another  characteristic  that  may  distinguish  the  regula- 
tion  of particular autoAbs  is  the  nature  of the  target  au- 
toAg.  In particular, the  site and  timing of expression and 
the  conformation  of a  target  Ag  could  affect  whether  B 
cells specific for it are tolerized. In the case of P,F, the fact 
that  the Ag (IgG2a)  can  be  complexed with foreign pro- 
teins is relevant.  This complex Ag would attract activated 
Th cells to tkF B  cells and these could break or prevent tol- 
erance.  In  addition,  B  cells have  FcP,  HII,  which  may  be 
coligated when  B  cells brad  immune  complexes  via  slg. 
Since  coligation of FcP,.',/II and  slg can  inhibit activation 
during immunization (44), it is possible that a similar signal 
could inhibit tolerance. Presumably, these mechanisms may 
also explain why P,F is a  dominant autospecificity. In any 
case, an understanding of why certain Ags are preferred tar- 
gets in various autoimnmne  disease will be  critical to  un- 
derstanding the  pathogenesis,  and  knowing  that  an  1LF  B 
cell is not centrally tolerized is an important step in this di- 
rection.  Experiments  in  progress  examining  P, Fs  with 
higher affinity should distinguish whether affinity for or na- 
ture  of the  target Ag explains the lack of tolerance of the 
AM14 1LF. 
That  self-specific AM14  B  cells are  imnmnocompetent 
shows that regulation of autoAbs in normal mice does not 
simply depend  on  central  tolerance  or peripheral  anergy. 
Several studies have  demonstrated  that  the normal preinl- 
nmne  repertoire does contain self-reactive B  cells, includ- 
ing RFs and anti-DNA, and that they can be activated un- 
der certain conditions (e.g., LPS) (17,  18, 45, 46). Whether 
these  cells  are  in  fact  the  precursors  of autoAb-secreting 
clones has  not been  established, but  here  we  demonstrate 
that a clone which is known  to be relevant can develop in 
the normal preimmune  repertoire.  It thereby suggests that 
at least some of these self-specific IZF clones in the normal 
preimmune repertoire are likely to be the precursors to dis- 
ease-related autoAbs. This scenario may apply to other au- 
toAb specificities as well. 
A  corollary to  this point is that in  autoimnmne  mice,  a 
failure of central tolerance need not occur to generate acti- 
vated  autoreactive  B  cell  clones.  This  raises  the  issue  of 
which  regulatory  mechanisms  do  prevent  autoreactive  B 
cell  clonal  expansion  in  normal  mice.  Recent  work  of 
Rathmell  and  colleagues  (47)  suggests  that  autoimmunity 
can  result  fiom  the  failure  to  eliminate  anergic  B  cells 
through  a  Fas-based  mechanism.  Our  results  show  that 
non-anergic  B  cells  may  also  be  precursors  for  autoAbs. 
Based on AM14  model, we hypothesize that systemic au- 
toimmune  disease is a  consequence  of defects either in  T 
cell tolerance or at later stages orb  cell regulation: for ex- 
ample, aberrant activation of and/or failure to appropriately 
downregulate  an  anti-self response.  This  fits  well  with 
emerging data on the expression of Fas in B  cells that sug- 
gests a role for Fas in apoptosis of B  cells once activated in 
1276  Tolerance of RF B Cells in Normal Mice the  periphery  (48-50).  It  is  also  consistent with  observa- 
tions that the lpr defect does not grossly affect central dele- 
tion or anergy (51, 52). 
A  view  of the  selective origin  of pathologic autoAb in 
disease that is consistent with all of these data is as follows: 
The  precursors  of  cells  that  secrete  pathologic  autoAb 
would  not  be  tolerized in  either  normal  or  autoimmune 
mice. Autoimmune  disease could ensue  if, once  activated, 
these  clones  somatically mutate,  are  selected by  autoAg, 
and ultimately yield high affinity pathogenic autoAbs. Au- 
toimmune individuals may be particularly prone to activate 
such  normally quiescent  cells and/or  may be  impaired in 
the ability to downregulate them once activated. 
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